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Quantifying Concentration of 33-mer in Wheat Flour
K.A. Howell, A.E. Rivas, R.L. Paris, and K.M. Pauley 
Department of Science and Mathematics, Cedarville University, Cedarville, OH 45314
Celiac Disease is a type IV hypersensitive response to gluten caused by HLA-DQ2 or 
HLA-DQ8 T-cell presentation, initiating destruction of intestinal epithelial cells. 
Currently, the only remedy for those suffering from celiac disease is the complete 
elimination of all gluten from the diet.  Studies indicate that an indigestible fragment of 
the gluten molecule, alpha-gliadin subcomponent 33-mer, rich in proline and 
glutamine, is responsible for the hypersensitivity response.  Determination of 33-mer 
concentration in wheat lines could be beneficial to the future development of wheat 
lines with reduced 33-mer concentration.  In this study, gliadin protein from wheat 
flour was extracted and separated from other proteins of wheat flour.  The extract of 
gliadin was then subjected to enzyme-linked immunosorbent assay (ELISA) technique 
in order to quantify the concentration of the 33-mer fragment.  This is the critical next-
step in allowing us to identify and develop wheat lines with reduced concentrations of 
33-mer.  It is possible that wheat with reduced 33-mer may be suitable for consumption 
by individuals with celiac disease. 
Previously, the protein concentration in the wheat flour extraction samples was 
confirmed through a serial dilution of the protein extract with 4 sample concentrations 
at 1mg/mL, 100 µg/mL, 10µg/mL, and 1µg/mL. Enzyme-Linked Immunosorbent 
Assay (ELISA) was used to specially tag the protein of interest, 33-mer, and confirm 
the concentration gradient.  In the first stage of this process a sample of wheat flour 
was compared to a gliadin standard. Using 1 mL extracted gliadin, a series of dilution 
were performed using coding buffer. Following the dilutions, the samples were 
incubated in a dark refrigerator overnight.  The wells were then aspirated and washed 
with PBS/Tween-20. 0.5% blocking buffer and allowed to rest overnight. Primary 
antibody (anti-gliadin) was diluted with 0.5% blocking buffer at a ratio of 1μL:10mL, 
and after repeated dilutions into ELISA wells, the plates were incubated for two hours 
at room temperature (37°C). The following day, the plates were aspirated and washed 
with PBS/Tween, diluted with the secondary antibody (Anti-Mouse-HRP) in blocking 
buffer at 1μL:5mL. The secondary antibody was then added to the ELISA wells for 
one hour at room temperature. After removing the liquid, the substrate was added 
(50mL:50mL:1μL) to each well. The ELISA plate was then visualize on the Glomax 
Microliter Plate
The ELISA results were not highly correlated with  the expected linear range of 
concentrations within the seven serial dilutions.  Decreasing ELISA signal would be 
expected to be associated with decreasing protein concentration.  The unexpected data  
may be due to low levels of analyte concentrations established in the wells. The next 
samples are proposed to have a higher analyte concentration in an effort to correct the 
problem. 
The gliadin protein was successfully isolated and used to create a serial dilution series.  
ELISA was then used to identify the 33- mer fragment of interest. Refinement of this 
procedure is required to successfully quantify the concentration 33-mer in each sample.
Further research needs to be conducted in order to refine the protocol for detection of 
the presence of the 33-mer concentration in wheat flour.  This will allow screening of 
multiple wheat lines, and determination of genetic diversity for breeding and selection. 
This could lead to the development of a wheat line containing reduced 33-mer 
concentrations, which may be safe for individuals with CD to consume without the 
adverse health effects of traditional gluten products.
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Celiac Disease (CD) is a gluten hypersensitivity characterized by severe physical 
symptoms caused by genetic and environmental factors. Genetically, 90-95% of CD 
patient’s T-cells respond to the gluten derived peptides presented by HLA-DQ2 or 
HLA-DQ8 cell surface receptors that trigger the destruction of intestinal epithelial cells 
(Tian, et.al, 2015). Environmentally, CD is triggered by the ingestion of gluten, a 
general term referring to to the aggregation of the storage proteins gliadin and glutenin 
(Van den Broeck, et al, 2009), which are found in wheat (Triticum aestivum L.), barley 
(Hordeum vulgare L.), and rye (Secale cereale L.). Gliadin is further subclassified into 
alpha, beta, and gamma subcomponents. Studies indicate that an indigestible alpha 
gliadin subcomponent, rich in proline and glutamine, is responsible for the 
hypersensitivity response. The presence of such amino acids make this alpha-9 gliadin 
subcomponent resistant to digestion by proteases, which is unaffected by normal 
digestion (Hollon, et al, 2015). Studies show that this particular epitope of gliadin, 
alpha-9, disrupts digestive processes most dramatically (van de Broek, et. al., 2009). Of 
particular interest is the peptide sequence, 33-mer, that binds to the HLA-DQ complex 
and then to T-cell receptors, triggering an adaptive immune response resulting in 
inflammation, and ultimately death of intestinal cells, giving rise to the characteristic 
symptoms of CD (Barone, et.al, 2015). Development of wheat lines with reduced 33-
mer may be valuable to individuals suffering from CD. Such a wheat variety may not 
trigger an autoimmune response, permitting CD patients to eat gluten-containing foods 
without experiencing adverse side effects. 
Introduction
Figure 1: ELISA 4 Graph
Table 1: ELISA 4 Test Data
